Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience-Reference-Cited by-同舟云学术

Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience

Published:2015-06-08 Issue:2 Volume:171 Page:247-253
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Miano Maurizio¹,Scalzone Maria¹,Perri Katia¹,Palmisani Elena¹,Caviglia Ilaria²,Micalizzi Concetta¹,Svahn Johanna¹,Calvillo Michaela¹,Banov Laura¹,Terranova Paola¹,Lanza Tiziana¹,Dufour Carlo¹,Fioredda Francesca¹

Affiliation:

1. Clinical and Experimental Haematology Unit; Giannina Gaslini Children's Hospital; Genova Italy

2. Infectious Disease Unit; Giannina Gaslini Children's Hospital; Genova Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13533/fullpdf

Reference21 articles.

1. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor;Acquazzino;Pediatric Transplantation,2013

2. Immunosuppressive drugs: the first 50 years and a glance forward;Allison;Immunopharmacology,2000